Grants per year
- 125 - 150 out of 546 results
Search results
-
The Role BH3 and Multi BH Domain Genes in Regulating Monocyte Survival and Function
Perlman, H. R. (PD/PI)
National Institute of Allergy and Infectious Diseases
9/1/08 → 7/31/10
Project: Research project
-
CAREER: Studies of Autoimmunity and Atherosclerosis
Majka, D. S.
National Institute of Allergy and Infectious Diseases
9/1/07 → 7/31/10
Project: Research project
-
CAREER: Studies of Autoimmunity and Atherosclerosis
Majka, D. S.
National Institute of Allergy and Infectious Diseases
9/1/07 → 7/31/10
Project: Research project
-
Prot# SL105: The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study
Ramsey-Goldman, R. (PD/PI)
7/1/08 → 7/31/10
Project: Research project
-
The Role of IL-27 in Experimental Arthritis
Pope, R. M. (Co-Investigator)
Arthritis National Research Foundation
9/1/08 → 7/31/10
Project: Research project
-
Prot# 104RA203: A Phs 2b, Rndmzd, Dbl-Blnd, Plcb-Cntrlld, Mltcntr Stdy to Evlut the Effcy, Sfty, Pharmacokinetics, and Pharmacodynamics of BG9924 When Gvn in Cmbntn w/ Methotrexate to Subs w/ Actv Rheumatoid Arthritis Who Have Had an Indqut Rspnd to Anti-
Ruderman, E. M. (PD/PI)
8/7/07 → 8/7/10
Project: Research project
-
Prot# 104RA203: A Phs 2b, Rndmzd, Dbl-Blnd, Plcb-Cntrlld, Mltcntr Stdy to Evlut the Effcy, Sfty, Pharmacokinetics, and Pharmacodynamics of BG9924 When Gvn in Cmbntn w/ Methotrexate to Subs w/ Actv Rheumatoid Arthritis Who Have Had an Indqut Rspnd to Anti-
Ruderman, E. M. (PD/PI)
8/7/07 → 8/7/10
Project: Research project
-
Prot# WA20495 / ACT3986g: A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients with Active Rheumatoid Arthritis who have an Inadequate Response to at Least One A
Ruderman, E. M. (PD/PI)
Quintiles, Inc., Genentech, Inc
8/10/07 → 8/10/10
Project: Research project
-
Prot# WA20495 / ACT3986g: A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients with Active Rheumatoid Arthritis who have an Inadequate Response to at Least One A
Ruderman, E. M. (PD/PI)
Quintiles, Inc., Genentech, Inc
8/10/07 → 8/10/10
Project: Research project
-
Prot# IFN3958g: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Escalating Single-and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of rhuMAb IFNalpha in Adults with Mildly Active Systemic Lupus Erythematosus
Ramsey-Goldman, R. (PD/PI)
8/16/07 → 8/16/10
Project: Research project
-
Prot# IFN3958g: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Escalating Single-and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of rhuMAb IFNalpha in Adults with Mildly Active Systemic Lupus Erythematosus
Ramsey-Goldman, R. (PD/PI)
8/16/07 → 8/16/10
Project: Research project
-
Prot# LBSL02: A Phs 2, Mlti-Cntr, Dbl-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, & Efficacy of LymphoStat-B? Antibody (Monoclonal Anti-BLyS Antibody) in Subjects w/Systemic Lupus Erythematosus (SLE)
Ramsey-Goldman, R. (PD/PI)
11/14/03 → 8/21/10
Project: Research project
-
Prot# LBSL02: A Phs 2, Mlti-Cntr, Dbl-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, & Efficacy of LymphoStat-B? Antibody (Monoclonal Anti-BLyS Antibody) in Subjects w/Systemic Lupus Erythematosus (SLE)
Ramsey-Goldman, R. (PD/PI)
11/14/03 → 8/21/10
Project: Research project
-
Prot# GL02-01: A Randomized, Double-Blind, Multi-Center, Placebo Controlled Study to Assess Prevention of Bone Loss by Treatment with Gl701 (Prestara?) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids
Ramsey-Goldman, R. (PD/PI)
1/31/03 → 8/21/10
Project: Research project
-
Prot# GL02-01: A Randomized, Double-Blind, Multi-Center, Placebo Controlled Study to Assess Prevention of Bone Loss by Treatment with Gl701 (Prestara?) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids
Ramsey-Goldman, R. (PD/PI)
1/31/03 → 8/21/10
Project: Research project
-
Prot# 13G01: A Phase 1 Dose Escalation Study of Repeat Intra-Articular Administration of tgAAC94, A Recombinant Adeno-Associated Vector Containing the TNFR:Fc Fusion Gene, in Inflammatory Arthritis Subjects With and Without Concurrent TNF-alpha Antagonist
Ruderman, E. M. (PD/PI)
1/23/06 → 9/9/10
Project: Research project
-
Prot# WA18063B: A Rndmzd, Dbl-Blnd, Plcb-Cntrlld, Prllel Grp Stdy of the Sfty & Rdctn of Sgn & Symptms Drng Trtmnt w/ MRA vs Plcb, In Cmbntn w/ Trdtnl DMARD Thrpy in Ptnts w/ Mdrt to Svre Actv Rhumtd Arthrts & an indqt rspns to crrnt DMARD Thrpy
Ruderman, E. M. (PD/PI) & Schnitzer, T. J. (Co-PD/PI)
7/11/05 → 9/10/10
Project: Research project
-
Prot# 16.0023: Open-Label Extension Treatment with TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trial 016.0012
Ruderman, E. M. (PD/PI)
12/4/00 → 9/10/10
Project: Research project
-
Prot# 120-20: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis Who Have Had an Inadequeate Respo
Ruderman, E. M. (PD/PI)
IDEC Pharmaceuticals Corporation
5/6/03 → 9/10/10
Project: Research project
-
Prot# WA18062: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Reduction of Signs and Symptoms During Treatment with MRA vs. Placebo, in Combination with Methotrexate in Patients with Moderate to Sever
Ruderman, E. M. (PD/PI)
9/23/05 → 9/11/10
Project: Research project
-
Prot# 016.0018: Open-Label Extension Treatment with TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trials
Ruderman, E. M. (PD/PI)
12/4/00 → 9/11/10
Project: Research project